GCT Semiconductor Insider Form 4: 75,000 RSUs to CTO Kim Jeong-Min
Rhea-AI Filing Summary
Kim Jeong-Min, Chief Technology Officer of GCT Semiconductor Holding, Inc. (GCTS), was granted 75,000 restricted stock units (RSUs) on 09/19/2025. The RSUs are a contingent right to receive one share of common stock each and vest in four equal annual installments of 25% beginning on 09/19/2026, subject to continued service. After the grant the reporting person beneficially owned 302,701 shares. The Form 4 was signed by an attorney-in-fact on 09/22/2025. The filing documents a standard executive equity award intended for retention and aligns the officer’s compensation with shareholder value.
Positive
- 75,000 RSUs awarded to the CTO, indicating executive retention and alignment with shareholder incentives
- Clear vesting schedule (25% annually over four years) promotes continued service
Negative
- No grant-value disclosed, so the financial impact and potential dilution cannot be assessed from this filing
- Unable to determine materiality because the filing does not state total outstanding shares or market capitalization
Insights
TL;DR: A routine executive RSU grant that vests over four years, typical for retention and alignment.
The award of 75,000 RSUs to the CTO is structured as time-based restricted stock units that convert to common shares on vesting. Vesting in equal annual installments over four years is a common design to promote retention. The reported post-transaction beneficial ownership of 302,701 shares provides context on the officer’s existing stake but the filing does not disclose total outstanding shares or grant value, so materiality relative to market capitalization cannot be assessed from this form alone.
TL;DR: Standard equity compensation disclosure; no derivatives or dispositions reported.
The Form 4 shows a non-derivative acquisition code for RSUs and confirms the grant price is $0 because RSUs are contingent rights to shares rather than purchased units. There are no dispositions or option exercises reported. The filing is procedural and compliant with Section 16 reporting requirements; it lacks valuation or grant-date fair value details that would allow assessment of dilution or expense impact.